Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03429790
Other study ID # CSCS
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date December 31, 2020

Study information

Verified date October 2018
Source Wenzhou Medical University
Contact Ting LI, M.D.
Phone 00447570150148
Email liting1021@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purposes of this study are:

1. To compare the difference of blood loss of the patients undergoing cesarean section between intraoperative blood recovery and allogeneic blood transfusion.

2. To compare the safety of the two methods.

3. To evaluate the medical cost and the overall cost of the two methods.


Description:

Preoperative: 1.To select patients according to the criteria.2.To obtain the consent of the obstetrician, the anesthesiologist, and the patients.

Intraoperative:According to local blood transfusion guidelines, obstetric advice, anesthesia advice(tentative: before a blood transfusion maternal's Hb less than 70g/L or Hb:70-100g/l before a blood transfusion according to the blood transfusion program and doctor's determine to do the blood transfusion),those who need blood transfusion during cesarean section will be randomly assigned to the following two groups:

1. cesarean section using intraoperative blood recovery group (test group).

2. cesarean section using allogeneic blood transfusion group (control group).

The theoretical amount of blood transfusion should be based on the following formula:

The amount of blood transfusion needed (ML) * Hb= (Hb2-Hb1) * blood volume of blood transfusion Hb1: actual measured hemoglobin; Hb2: target hemoglobin (100 g / L) Blood volume = 100ml/kg * body weight The difference between the actual blood transfusion and the theoretical blood transfusion should be controlled within ± 15% of the theoretical blood transfusion (in terms of hemoglobin), whether the test group or the control group.

Postoperative: Calculate the amount of bleeding in the subjects and other related indicators.

Follow up: maternal pregnancy again: detection of maternal blood group antibody IgG titer, hemolytic disease of the newborn Statistical data: the specially assigned person is responsible for the data collection. And the data is entryed by two times (the first phase: hospitalization period, the second phase: follow-up), which is by the inspectors to verify the authenticity and traceability.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date December 31, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Delivery by elective or emergency caesarean section with an identifiable increased risk of haemorrhage.

- Ability to provide informed consent

- Participants need blood transfusion

Exclusion Criteria:

- Hb<70g/L before operation

- Participants have a history of blood transfusion

- Blood type is RH blood type

- Sickle cell disease

- The obstetricians and anesthesia doctors think some cases existing intraoperatie blood recycling contraindications

- PT and APTT is 1.5 times longer than normal and above, or platelet is less than 50 * 109 / L preoperative

- Cultural or social beliefs contraindicating blood transfusion.

- Significant antibodies making it difficult to find cross matched blood for transfusion

- participation in another clinical trial within 3 months prior to selection

- ability to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
intra-operative cell salvage
intra-operative cell salvage collects the patient's blood lost during an operation, processes it and returns it to their own circulation.
allogeneic blood transfusion
transfuse allogeneic blood to patients if blood transfusion is needed.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wenzhou Medical University

References & Publications (9)

Bodelon C, Bernabe-Ortiz A, Schiff MA, Reed SD. Factors associated with peripartum hysterectomy. Obstet Gynecol. 2009 Jul;114(1):115-23. doi: 10.1097/AOG.0b013e3181a81cdd. — View Citation

Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, Millward-Sadler H, Neilson J, Nelson-Piercy C, Norman J, O'Herlihy C, Oates M, Shakespeare J, de Swiet M, Williamson C, Beale V, Knight M, Lennox C, Miller A, Parmar D, Rogers J, Springett A. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011 Mar;118 Suppl 1:1-203. doi: 10.1111/j.1471-0528.2010.02847.x. Erratum in: BJOG. 2015 Apr;122(5):e1. BJOG. 2015 Apr;122(5):e1. — View Citation

Catling S. Intraoperative cell salvage in obstetrics. Clin Risk 2008 Jan 1;14(1):14-7.

Elagamy A, Abdelaziz A, Ellaithy M. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth. 2013 Nov;22(4):289-93. doi: 10.1016/j.ijoa.2013.05.007. Epub 2013 Aug 16. — View Citation

Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv. 2005 Oct;60(10):663-71. Review. — View Citation

Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. Br J Anaesth. 2008 Aug;101(2):225-9. doi: 10.1093/bja/aen135. Epub 2008 May 30. — View Citation

Sullivan IJ, Hicks MK, Faulds JN, Carson PJ, Noble RS. A modified thrombin clotting time test as a quality control marker for heparin contamination in obstetric intraoperative cell salvage. Transfus Med. 2012 Feb;22(1):68-70. doi: 10.1111/j.1365-3148.2011.01123.x. Epub 2011 Dec 16. — View Citation

Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000 Jun;92(6):1531-6. — View Citation

Zheng J, Du L, Du G, Liu B. Coagulopathy associated with cell salvage transfusion following cerebrovascular surgery. Pak J Med Sci. 2013 Nov;29(6):1459-61. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary blood loss of the subjects in 5 days of after operation calculate the changes of Hct and the amount of blood transfusion in fifth day post operation
Secondary postoperative Hct in first day post operation the Hct in first day post operation in first day post operation
Secondary postoperative Hb in first day post operation the Hb in first day post operation in first day post operation
Secondary postoperative PT in first day post operation the PT in first day post operation in first day post operation
Secondary postoperative APTT in first day post operation the APTT in first day post operation in first day post operation
Secondary postoperative Hct in the fifth day post operation the Hct in fifth day post operation in the fifth day post operation
Secondary postoperative Hb in the fifth day post operation the Hb in fifth day post operation in the fifth day post operation
Secondary postoperative PT in the fifth day post operation the PT in fifth day post operation in the fifth day post operation
Secondary postoperative APTT in the fifth day post operation the APTT in fifth day post operation in the fifth day post operation
Secondary Total intraoperative and postoperative blood transfusion calculate the amount of blood transfusion from the date of operation until the date of hospital discharge, assessed up to 7 days
Secondary Length of hospital stay calculate the length of hospital stay from the date of operation until the date of hospital discharge, assessed up to 7 days
Secondary first mobilization calculate the time to first mobilization from the date of operation up to first mobilization, assessed up to 7 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03651154 - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections N/A
Completed NCT01136590 - Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery Phase 4
Completed NCT00097006 - Retrovirus Epidemiology Donor Study-II (REDS-II) N/A
Completed NCT00005303 - Effectiveness of AIDS Antibody Screening N/A
Completed NCT00005319 - Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine N/A
Completed NCT00005301 - Transfusion Safety Study (TSS) N/A
Completed NCT00000581 - Granulocyte Transfusion Study Phase 3
Completed NCT04089865 - Oral Versus Intravenous Tranexamic Acid Phase 4
Completed NCT02968654 - TRansfusion Strategies in Acute Brain INjured Patients N/A
Enrolling by invitation NCT06019364 - Transfusion of Whole Blood in Acute Bleeding
Completed NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery Phase 4
Completed NCT03727230 - RhD+ Blood Transfusion to Asian-type DEL Recipients N/A
Recruiting NCT06102590 - Oxygen Extraction-guided Transfusion N/A
Completed NCT00400192 - Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury N/A
Completed NCT00000593 - Viral Activation Transfusion Study (VATS) N/A
Completed NCT05627544 - Blood Transfusion Applications in Hip Replacements
Completed NCT05581238 - Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
Completed NCT00822588 - Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not N/A
Withdrawn NCT00269971 - A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. Phase 3
Completed NCT03930355 - Perioperative Transfusion Related Outcome